Taylor & Francis Group
Browse
tbsd_a_1765874_sm4176.docx (147.23 kB)

Insilico analysis of marine indole alkaloids for design of adenosine A2A receptor antagonist

Download (147.23 kB)
Version 2 2020-06-04, 16:04
Version 1 2020-05-07, 09:31
journal contribution
posted on 2020-06-04, 16:04 authored by Nitin Lonikar, Prafulla Choudhari, Omprakash Bhusnuare

Neurological disease is the disease associated with most of geriatric population in the world. The diseases like Alzheimer’s disease and Parkinson’s disease are associated with the change in the life style in current era. Treatment of these diseases normally focused on the agents which can able to manipulate the neurotransmitter release, so it is associated with severe side effects. Adenosine receptors are the upcoming targets for the inflammatory as well as neurological diseases as agents like istradefylline are in the clinical use. Marine natural products are the rich source of the valuable drug like substances, number marine alkaloids are known for their ability to pass blood brain barrier (BBB) which is major hurdle in the neurological drug discovery. Here, we report the virtual screening of some marine alkaloids for adenosine 2 receptor binding potential. Results indicated topsentin C, 6′-debromohamacanthin, 6-hydroxydiscodermindole and discodermindole are having excellent binding affinity towards the adenosine 2A receptor than other selected alkaloids.

Communicated by Ramaswamy H. Sarma

History